Immediate percutaneous renal mass biopsy following cryoablation: validation of diagnostic performance and clinical outcomes
- 20 June 2026
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (12) , 6631-6635
Abstract
Objectives Image-guided thermal ablation is a guideline-supported treatment for small renal tumors. While biopsy is recommended, the optimal timing relative to ablation remains undefined. Pre-ablation biopsy may complicate ablation through hemorrhage, impaired target visualization, and potential tumor seeding. Post-cryoablation biopsy has been described in a small cohort of patients, but reproducibility has not been established. This study evaluated the diagnostic performance and clinical outcomes of renal mass biopsy performed immediately after cryoablation in a single session. Methods This retrospective, single-center study included patients who underwent image-guided percutaneous cryoablation followed by immediate post-ablation core needle biopsy, performed at operator discretion, between December 2018 and April 2025. After active or passive thaw and probe removal, at least two 18-gauge core biopsy samples were obtained per lesion using a coaxial needle. Specimens were formalin-fixed and reviewed by pathology. Outcomes included specimen adequacy, histopathologic diagnosis, adverse events, imaging response, and tumor recurrence or seeding. Follow-up imaging and labs were performed at 3 and 6 or 9 months, then annually. Results Twenty-six solid enhancing renal masses (mean size 2.5 cm, range 1.4–4.7 cm) in 24 patients were included. All biopsy specimens were diagnostic with histologic diagnoses including renal cell carcinoma (RCC, n = 19), oncocytoma (n = 6), and metanephric adenoma (n = 1), with RCC subtypes including clear cell, papillary, chromophobe, sarcomatoid, and mixed histology. Complications were limited to the immediate post-procedural period, with no delayed adverse events or chronic sequelae. All lesions demonstrated complete radiographic response on 3-month follow-up imaging. There were no cases of tumor recurrence or seeding observed over a median follow-up of 1,415 days. Conclusion Immediate post-cryoablation renal mass biopsy is diagnostically reliable and may provide benefit in clinical practice.Keywords
This publication has 13 references indexed in Scilit:
- Diagnostic Yield of Percutaneous Core Needle Biopsy Immediately After CryoablationCardioVascular and Interventional Radiology, 2025
- Comparison of coaxial technique with sequential (non-coaxial) technique for renal mass biopsy: evaluation of diagnostic efficacy, complication rates, seeding risk, and clinical outcomesEuropean Radiology, 2025
- Complications After Renal Mass Biopsy: Frequency, Nature, Timing, and Associated CharacteristicsAmerican Journal of Roentgenology, 2023
- Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part IJournal of Urology, 2021
- Risk Factors for Complications and Nondiagnostic Results following 1,155 Consecutive Percutaneous Core Renal Mass BiopsiesJournal of Urology, 2019
- Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta‐analysisBJU International, 2017
- Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology, 2017
- Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the LiteratureJournal of Urology, 2016
- Histopathologic Findings of Small Renal Tumor Biopsies Performed Immediately After Cryoablation TherapyAmerican Journal of Clinical Pathology, 2014
- Comparison of the Histologic Accuracy of Needle Biopsy Before and After Renal Cryoablation: Laboratory and Initial Clinical ExperienceUrology, 2007